Gastroenterology

A Wealth of Experience

We have collaborated with our clients on projects to research gastrointestinal (GI) disease, GI treatment, and complications and comorbidities of GI disease.  Our experience includes:

  • Celiac disease
  • Chronic idiopathic constipation
  • Crohn’s disease
  • Diverticulitis
  • Dyspepsia
  • Gastroesophageal reflux disease (GERD)
  • Pediatric GERD
  • Gastroparesis
  • Gastric cancer
  • Irritable bowel syndrome (IBS) (diarrhea-predominant & constipation-predominant)
  • Opioid-induced constipation
  • Postoperative ileus
  • Ulcerative colitis

Types of Projects

We have implemented studies to help our clients develop strategies in the gastrointestinal (GI) market and to develop and gain market access for products to treat GI diseases and complications arising from treatment of GI illnesses. Recent projects have included:

Our Experts

Dawn Odom
Vice President, Biostatistics
Shahnaz Khan
Executive Director, Market Access and Outcomes Strategy
Lynne Hamm
Vice President, Clinical and Medical Services
Allen Mangel
Executive Vice President, RTI Health Solutions and Discovery Sciences, RTI Chief Medical Officer
Rebecca Crawford
Director, Patient-Centered Outcomes Assessment
Annete Njue
Senior Director, Market Access and Outcomes Strategy
Sheri Fehnel
Vice President, Patient-Centered Outcomes Assessment
Sean Candrilli
Vice President, Health Economics
Valerie Williams
Senior Director, Psychometrics, Patient-Centered Outcomes Assessment
James Twiss
Director, Patient-Centered Outcomes Assessment
Bintu Sherif
Director, Biostatistics
Ann Colosia
Associate Director, Market Access and Outcomes Strategy
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Elena Rivero
Senior Director, Epidemiology
Carol Mansfield
Senior Economist and Head, Health Preference Assessment
Katie Houghton
Director, Health Economics
Lauren Nelson
Executive Director, Psychometrics, Patient-Centered Outcomes Assessment
David McSorley
Director, Biostatistics
Jin Yang
Associate Director, Market Access and Outcomes Strategy
Caroline Ling
Executive Director and HTA Specialist, Market Access and Outcomes Strategy
Claire Ervin
Senior Director, Patient-Centered Outcomes Assessment
Stephanie Earnshaw
Senior Vice President, Health Economics
Daniel Mines
Senior Epidemiology Consultant
Keith Davis
Senior Director, Health Economics
Kelly Hollis
Vice President, Surveys and Observational Studies

Selected Recent Gastroenterology Publications